Loading organizations...
Loading organizations...
Science-based interventions for convenient health solutions.
Mave Health develops and produces a neurotechnology wearable designed to enhance cognitive performance and mental well-being. The company's core product is a neuromodulation headset that utilizes targeted, low-intensity electrical signals, specifically transcranial direct current stimulation (tDCS), to improve users' stress regulation, focus, and overall mood through daily, short sessions. This approach represents a non-invasive method for influencing brain activity and promoting cognitive and emotional balance.
The company was founded in 2023 by Dhawal Jain, Jai Sharma, and Aman Kumar, establishing its operations across San Francisco and Bengaluru. Their collective insight centered on the potential of neurostimulation technologies to address widespread challenges in mental health and cognitive function, identifying a market need for accessible, wearable solutions that empower individuals to proactively manage their psychological states. This led to the development of a personal device for at-home use.
Mave Health's product is aimed at individuals seeking to optimize their mental performance and emotional resilience. The company envisions a future where personalized neurotechnology provides an intuitive and effective tool for daily brain health maintenance, fostering greater attention, reduced stress, and enhanced mood for its users. Their long-term objective is to integrate advanced brain stimulation into routine self-care practices.
Mave Health has raised $4.8M across 3 funding rounds.
Mave Health has raised $4.8M in total across 3 funding rounds.
Mave Health is a Bengaluru-based health tech startup founded in 2023 that develops wearable devices using non-invasive brain stimulation (NIBS), specifically transcranial direct current stimulation (tDCS), to treat depression and mental health issues.[1][2][3] The company's flagship product, Arc, is a headset that delivers gentle electrical currents to the prefrontal cortex, enhancing cognition, emotional regulation, focus, and stress management in just 20 minutes daily, backed by over 25 years of clinical research.[1][3] It serves mental health patients—branded as "Mavericks"—through hyper-personalized programs combining device access, unlimited expert sessions (doctors, psychologists, nutritionists, fitness coaches), and psychiatric care, solving India's mental health crisis by offering non-pharmacological, at-home alternatives to traditional treatments.[1][3] With pre-seed funding of $719.65K raised in April 2024, 20-52 employees, and early traction from one enrolled batch, Mave shows promising growth in patient management and digital care continuity.[2][4]
Mave Health emerged from founders' research into depression treatments amid India's mental health challenges, leading them to NIBS and tDCS technologies.[1] Led by CEO (Founder & Chief Executive Officer) and CTO (Co-Founder & Chief Technology Officer), the team launched in 2023 as a medtech company focused on mental health services and platforms.[1][4] Early development centered on importing tDCS devices from foreign manufacturers while building a high-touch model with expert-guided programs; they've since enrolled their first batch of patients, marking initial traction in a space where traditional mental healthcare lags.[1][2]
Mave Health rides the global mental health tech wave, amplified in India where depression affects millions but access to care is limited by stigma, scarcity, and outdated methods.[1][5] Timing aligns with rising demand for non-pharmacological neuromodulation post-COVID stress surges, leveraging wearable tech trends like those in fitness (e.g., Whoop, Oura) now extending to brain health.[1][3] Market forces favor it: growing medtech funding in India, tDCS's established safety profile, and digital therapeutics' scalability amid healthcare digitization.[2][4] By influencing the ecosystem, Mave pioneers at-home brain stimulation, potentially reducing reliance on meds and therapists while normalizing mental health via consumer-friendly wearables.[1][3]
Mave Health is poised to scale its Arc programs with domestic manufacturing, more batches, and expanded indications beyond depression, fueled by recent pre-seed capital and 15K monthly web traffic.[2] Trends like AI-personalized neuromodulation, telehealth integration, and Asia's mental health boom will shape its path, possibly attracting Series A amid $7.6M revenue projections.[4] Its influence could evolve from niche player to category leader, democratizing brain health and redefining mental care as proactive science, not reactive bandaids—unlocking peak potential for hustlers worldwide.[3][5]
Mave Health has raised $4.8M in total across 3 funding rounds.
Mave Health's investors include Arpit Agarwal, Dhaval Shroff, Juhi Bhatnagar, Raymond Russell, Kushal Bhagia, Utsav Somani, Better Capital, Deepinder Goyal, Dube, Ganeshprasad S, Gaurav Agarwal, Harsh Shah.
Mave Health has raised $4.8M across 3 funding rounds. Most recently, it raised $2.1M Seed in March 2026.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Mar 18, 2026 | $2.1M Seed | Arpit Agarwal | Dhaval Shroff, Juhi Bhatnagar, Raymond Russell |
| Apr 1, 2024 | $720K Seed | Kushal Bhagia, Utsav Somani | Better Capital, Deepinder Goyal, Dube, Ganeshprasad S, Gaurav Agarwal, Harsh Shah, Himanshu Aggarwal, Kunal Shah, Mohit Kumar, Nandan Reddy, Neel Gogia, Neel Mehta, Nikhil Kant, Nitin Mehrotra, Rajan Dube, Rohan Verma, Shlok Srivastava, Vatsal singhal, Vikrampati Singhania, Bharat Founders Fund |
| $2.0M Mave Health Seed Round | Blume Ventures, Arpit Agarwal |